logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Satoshi Kobayashi

Kanagawa Cancer Center
H指数:40
被引数:4,992

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Preoperative prognostic stratification of high-risk resectable pancreatic cancer: combined Podxl/itgb1 expression in EUS-FNAB specimens as a prognostic biomarker

术前高危可切除胰腺癌的预后分层：EUS-FNAB标本中Podxl/itgb1联合表达作为预后生物标志物

BMC Cancer
IF3.4
2026-10-020
OAAI
Kaoru Furihata; Masahiko Sakaguchi; Makoto Ueno; Satoshi Kobayashi; Tomoyuki Yokose; Ayano Nakazono; Dai Inoue; Tatsuya Hayashi; Yoshihiro Okawa; Mutsuo Furihata; Atsushi Kurabayashi; Kazushige Uchida; Keisuke Taniuchi
Nivolumab Plus Ipilimumab for Unresectable Hepatocellular Carcinoma in Early Real-World Clinical Practice: A Multicenter Analysis of Efficacy and Safety

纳武利尤单抗联合伊匹木单抗治疗不可切除肝细胞癌在早期真实世界临床实践中的疗效与安全性：一项多中心分析

Cancers
IF4.4
2026-08-280
OA
Hironao Okubo; Teppei Matsui; Makoto Chuma; Akihiro Funaoka; Haruki Uojima; Satoshi Narahara; Masahiro Kobayashi; Yuwa Ando; Tsunamasa Watanabe; Taito Fukushima; Satoshi Kobayashi; Katsuharu Hirano; Kota Tsuruya; Tatehiro Kagawa; Shuichiro Iwasaki; Hisashi Hidaka; Hidenari Nagai; Yasuhito Tanaka; Shin Maeda; Manabu Morimoto
Combination chemotherapy for older patients with unresectable biliary tract cancer: a prospective observational study using propensity-score matched analysis (JON2104-B)

不可切除性胆道癌老年患者的联合化疗：一项使用倾向性评分匹配分析的回顾性观察研究（JON2104-B）

Journal of Gastroenterology
IF5.5
2025-09-060
OAAI
Satoshi Kobayashi; Kohei Nakachi; Kouji Yamamoto; Makoto Ueno; Yuta Maruki; Kenji Ikezawa; Takeshi Terashima; Satoshi Shimizu; Kotoe Oshima; Kunihiro Tsuji; Yoshiharu Masaki; Hidetaka Tsumura; Taro Shibuki; Masato Ozaka; Naohiro Okano; Yukiyasu Okamura; Kumiko Umemoto; Tatsunori Satoh; Yasushi Kojima; Kazuhiko Shioji; Hiroko Nebiki; Toshifumi Doi; Atsushi Naganuma; Shigeki Kataoka; Emiri Kita; Hiroyuki Asama; Kaoru Tsuchiya; Michiaki Unno; Reiko Ashida; Kazuyuki Matsumoto; Izumi Ohno; Takao Itoi; Yuji Negoro; Yasunari Sakamoto; Shiho Arima; Akinori Asagi; Hiroyuki Okuyama; Yoshito Komatsu; Noritoshi Kobayashi; Hiroaki Nagano; Junji Furuse
Outcomes of FOLFIRINOX versus Gemcitabine plus nab-Paclitaxel in Patients with Early Recurrent Pancreatic Cancer after Adjuvant S-1 Treatment: A propensity Score-matched Analysis

FOLFIRINOX与吉西他滨联合nab-紫杉醇在S-1辅助治疗后早期复发性胰腺癌患者中的疗效比较：一项倾向性评分匹配分析

Pancreatology
IF2.7
2025-08-300
PRE
Naohiro Okano; Kentaro Sakamaki; Takafumi Mie; Kazuo Watanabe; Satoshi Kobayashi; Akiko Todaka; Yuko Suzuki; Hidetoshi Kitamura; Kazunari Tanaka; Kei Nakagawa; Keiko Kamei; Kumiko Umemoto; Nobuaki Azemoto; Yasuyuki Kawamoto; Hiroaki Yanagimoto; Kunihiro Tsuji; Hiroshi Imaoka; Takeshi Terashima; Chigusa Morizane; Masafumi Ikeda; Masato Ozaka; Makoto Ueno; Junji Furuse
Overexpression of Nuclear Factor of Activated T-cells (NFAT) Transcription Factors Drives Chemoresistance and Poor Outcomes in Pancreatic Cancer

核因子活化T细胞（NFAT）转录因子的过表达驱动胰腺癌的化疗抵抗和不良预后

Annals of Surgical Oncology
IF3.5
2025-08-280
PRE
Yuto Kamioka; Yukihiko Hiroshima; Wataru Kawase; Shinya Sato; Seira Hatakeyama; Kota Washimi; Rei Kanemoto; Shinnosuke Kawahara; Masaaki Murakawa; Toru Aoyama; Satoshi Kobayashi; Makoto Ueno; Naoto Yamamoto; Takashi Ohshima; Robert M. Hoffman; Yohei Miyagi; Yasushi Rino; Aya Saito; Soichiro Morinaga
Peritoneum carcinomatosis as a favourable prognostic factor for treatment with nanoliposomal irinotecan and fluorouracil plus leucovorin in advanced pancreatic cancer

腹膜癌病作为纳米脂质体伊立替康联合氟尿嘧啶和亚叶酸钙治疗晚期胰腺癌的有利预后因素

Therapeutic Advances in Medical Oncology
IF4.2
2025-06-260
OA
Satoshi Kobayashi; Taito Fukushima; Shun Tezuka; Kazumasa Shiraishi; Masato Enomoto; Shotaro Tsunoda; Tomomi Hamaguchi; Ritsuko Ohishi; Yuichiro Tozuka; Masaaki Murakawa; Naoto Yamamoto; Makoto Ueno; Junji Furuse; Shin Maeda
GnP vs mFOLFIRINOX or S-IROX in metastatic pancreatic cancer: 1-year follow-up updated data from the GENERATE (JCOG1611)

GnP与mFOLFIRINOX或S-IROX在转移性胰腺癌中的应用：GENERATE（JCOG1611）1年随访更新数据

ANNALS OF ONCOLOGY
IF65.4
2024-09-011
PRE
Kobayashi, S.; Ohba, A.; Ozaka, M.; Mizusawa, J.; Okusaka, T.; Yamashita, T.; Ikeda, M.; Yasuda, I.; Sugimori, K.; Sasahira, N.; Ikezawa, K.; Miki, I.; Okano, N.; Mizuno, N.; Furukawa, M.; Shirakawa, H.; Sano, Y.; Katayama, H.; Furuse, J.; Ueno, M.
Lenvatinib radiofrequency ablation sequential therapy offers survival benefits for patients with unresectable hepatocellular carcinoma at intermediate stage and the liver reserve of Child-Pugh A category: A multicenter study

仑伐替尼联合射频消融序贯治疗可为不可切除、处于中期且肝功能分级为Child-Pugh A级的肝细胞癌患者带来生存获益：一项多中心研究

HEPATOLOGY RESEARCH
IF3.4
2024-07-020
PRE
Zhang, Ying; Numata, Kazushi; Imajo, Kento; Uojima, Haruki; Funaoka, Akihiro; Komiyama, Satoshi; Ogushi, Katsuaki; Chuma, Makoto; Irie, Kuniyasu; Kokubu, Shigehiro; Yoneda, Masato; Kobayashi, Takashi; Hidaka, Hisashi; Fukushima, Taito; Kobayashi, Satoshi; Morimoto, Manabu; Kagawa, Tatehiro; Hattori, Nobuhiro; Watanabe, Tsunamasa; Iwase, Shigeru; Maeda, Shin
A randomised phase II study of modified FOLFIRINOX versus gemcitabine plus nab-paclitaxel for locally advanced pancreatic cancer (JCOG1407)

改良FOLFIRINOX与吉西他滨联合nab-紫杉醇治疗局部晚期胰腺癌的随机II期研究 (JCOG1407)

EUROPEAN JOURNAL OF CANCER
IF7.1
2023-03-0135
OAAI
Ozaka, Masato; Nakachi, Kohei; Kobayashi, Satoshi; Ohba, Akihiro; Imaoka, Hiroshi; Terashima, Takeshi; Ishii, Hiroshi; Mizusawa, Junki; Katayama, Hiroshi; Kataoka, Tomoko; Okusaka, Takuji; Ikeda, Masafumi; Sasahira, Naoki; Miwa, Haruo; Mizukoshi, Eishiro; Okano, Naohiro; Mizuno, Nobumasa; Yamamoto, Tomohisa; Komatsu, Yoshito; Todaka, Akiko; Kamata, Ken; Furukawa, Masayuki; Fujimori, Nao; Katanuma, Akio; Takayama, Yukiko; Tsumura, Hidetaka; Fukuda, Haruhiko; Ueno, Makoto; Furuse, Junji
Multicenter phase II trial of trastuzumab deruxtecan for HER2-positive unresectable or recurrent biliary tract cancer: HERB trial
FUTURE ONCOLOGY
IF2.6
2022-05-0541
OA
Ohba, Akihiro; Morizane, Chigusa; Ueno, Makoto; Kobayashi, Satoshi; Kawamoto, Yasuyuki; Komatsu, Yoshito; Ikeda, Masafumi; Sasaki, Mitsuhito; Okano, Naohiro; Furuse, Junji; Hiraoka, Nobuyoshi; Yoshida, Hiroshi; Kuchiba, Aya; Sadachi, Ryo; Nakamura, Kenichi; Matsui, Naoko; Nakamura, Yoshiaki; Okamoto, Wataru; Yoshino, Takayuki; Okusaka, Takuji
Safety and efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma in early clinical practice: A multicenter analysis

在早期临床实践中，阿特珠单抗联合贝伐单抗治疗不可切除的肝细胞癌患者的安全性和有效性: 多中心分析

HEPATOLOGY RESEARCH
IF3.4
2021-11-3037
PRE
Chuma, Makoto; Uojima, Haruki; Hattori, Nobuhiro; Arase, Yoshitaka; Fukushima, Taito; Hirose, Shunji; Kobayashi, Satoshi; Ueno, Makoto; Tezuka, Shun; Iwasaki, Shuichiro; Wada, Naohisa; Kubota, Kousuke; Tsuruya, Kota; Shimma, Yoshimasa; Hiroki, Ikeda; Takuya, Ehira; Tokoro, Chikako; Iwase, Shigeru; Miura, Yuki; Moriya, Satoshi; Watanabe, Tsunamasa; Hidaka, Hisashi; Morimoto, Manabu; Numata, Kazushi; Kusano, Chika; Kagawa, Tatehiro; Maeda, Shin

研究方向

暂未获取到该数据
M
Makoto Ueno
H 指数:45论文数:570被引数:1.0万
M
Manabu Morimoto
H 指数:42论文数:250被引数:8,226
T
Taito Fukushima
H 指数:18论文数:72被引数:768
S
Shin Maeda
H 指数:66论文数:859被引数:2.5万
H
Hisashi Hidaka
H 指数:63论文数:385被引数:1.6万
J
Junji Furuse
H 指数:75论文数:731被引数:2.8万
M
Masafumi Ikeda
H 指数:76论文数:1,020被引数:3.4万
N
Naohiro Okano
H 指数:20论文数:184被引数:1,977
K
Kazushi Numata
H 指数:50论文数:345被引数:1.2万
C
Chigusa Morizane
H 指数:49论文数:546被引数:9,260